Immunovant, Inc. IMVT Cash Flow Statement
| Q4 '26 | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | ||
|---|---|---|---|---|---|---|
| -$147.86M-38.9% | -$110.64M+0.4% | -$126.5M-15.9% | -$120.61M-38.4% | -$106.45M-41.3% | ||
| $96K-11.9% | $101K+2.0% | $105K+18.0% | $107K+33.8% | $109K+70.3% | ||
| $11.14M-4.7% | $12.72M+9.1% | $13.36M+5.2% | $18.51M+37.6% | $11.69M+20.7% | ||
| -$95.06M+14.1% | -$92.33M+8.0% | -$102.52M-15.6% | -$117.41M-54.1% | -$110.64M-85.3% | ||
| $8K-96.0% | $0-100% | $0-100% | $0-100% | $201K+34.0% | ||
| -$8K+96.0% | $0+100% | $0+100% | $0+100% | -$201K-34.0% | ||
| $3.64M-99.2% | $564.6M+22,814% | $24.6M+3,269% | $2.92M+325% | $450.61M+29,066% | ||
| —— | $472.66M+581% | -$77.04M+11.5% | -$115.06M-52.7% | $339.29M— | ||
| -$95.07M+14.2% | -$92.33M+8.2% | -$102.52M-15.4% | -$117.41M-53.7% | -$110.84M-85.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Immunovant, Inc. generate?
- Immunovant, Inc. (IMVT) generated -$407.3M in operating cash flow over the trailing twelve months.
- What is Immunovant, Inc.'s free cash flow?
- After $8.0K of capital expenditures, Immunovant, Inc.'s free cash flow was -$407.3M over the trailing twelve months, down 8.2% year over year.
- Where does Immunovant, Inc.'s cash flow data come from?
- Every line is extracted from Immunovant, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.